Novel approaches for therapy of chronic hepatitis C
- 30 June 2006
- journal article
- review article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 36 (2) , 87-94
- https://doi.org/10.1016/j.jcv.2006.02.003
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patientsJournal of Hepatology, 2006
- Isatoribine, an Agonist of TLR7, Reduces Plasma Virus Concentration in Chronic Hepatitis C Infection *Hepatology, 2005
- Pilot study of interferon gamma for chronic hepatitis CPublished by Elsevier ,2005
- NM 283, AN EFFICIENT PRODRUG OF THE POTENT ANTI-HCV AGENT 2′-C-METHYLCYTIDINENucleosides, Nucleotides and Nucleic Acids, 2005
- 492 A phase II, placebo-controlled study of merimepodib (XV-497), in combination with pegylated interferon-alfa, and ribavirin in patients with chronic hepatitis C non-responsive to previous therapy with interferon-alfa and ribavirinJournal of Hepatology, 2004
- Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled studyJournal of Hepatology, 2004
- Evaluation of amantadine in chronic hepatitis C: a meta-analysisJournal of Hepatology, 2004
- Past, Present, and Future Hepatitis C TreatmentsSeminars in Liver Disease, 2004
- A Multicenter Study of Recombinant Human Interleukin 12 for the Treatment of Chronic Hepatitis C Virus Infection in Patients Nonresponsive to Previous TherapyHepatology, 2003
- Interaction between the Hepatitis C Virus and the Immune SystemSeminars in Liver Disease, 2000